NCT05876156 iMOVE: Virtual Reality PT Versus Traditional PT
| NCT ID | NCT05876156 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Stanford University |
| Condition | Physical Health |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2025-06-01 with a primary completion date of 2026-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This pragmatic, crossover, randomized controlled study evaluates the efficacy of virtual reality assisted physical therapy (VRPT) for improving the physical activity of hospitalized children as compared to traditional physical therapy. This is a pilot study that will be used to identify patient populations that can benefit the most from VRPT and estimate this effect for future studies. Patients with a significant neurological condition, major developmental disability, active infection of the face or hand, history of severe motion sickness, history of seizures caused by flashing light or had a major surgery within the last 48 hours will be excluded.
Eligibility Criteria
Inclusion Criteria: * Between age 10-25 years * Diagnosed with cancer * Has an active physical therapy consultation * Anticipated inpatient stay for at least 3-days with the second PT session following between 24-72 hours after the first PT session * Ability to understand and the willingness to personally sign the written Institutional Review Board (IRB) approved informed consent document by Legally Authorized Representative (LAR) if participant \<18 years old or by participant if 18+ * Ability to understand and the willingness to personally sign the written IRB approved informed assent document for patient \<18 years old. Exclusion Criteria: * Legal guardian does not present to obtain consent. * Child with a significant neurological condition, or major developmental disability. * Child with active infection of the face or hand. * A history of severe motion sickness. * A history of seizures caused by flashing light. * Major surgery within the last 48 hours. * Does not speak English (required for surveys) * With visual impairments or any degree of developmental delays * Child on mechanical ventilation or ventilatory support
Contact & Investigator
Thomas Caruso
PRINCIPAL INVESTIGATOR
Stanford University
Frequently Asked Questions
Who can join the NCT05876156 clinical trial?
This trial is open to participants of all sexes, aged 10 Years or older, up to 25 Years, studying Physical Health. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05876156 currently recruiting?
Yes, NCT05876156 is actively recruiting participants. Contact the research team at tjcaruso@stanford.edu for enrollment information.
Where is the NCT05876156 trial being conducted?
This trial is being conducted at Palo Alto, United States.
Who is sponsoring the NCT05876156 clinical trial?
NCT05876156 is sponsored by Stanford University. The principal investigator is Thomas Caruso at Stanford University. The trial plans to enroll 40 participants.